Can Insomnia Be the First Sign of Perimenopause — Even Without Hot Flashes?

Yes. Progesterone declines before estrogen in early perimenopause, and since progesterone metabolites drive GABA-mediated sleep maintenance, insomnia can appear before hot flashes, irregular periods, or other recognizable changes. Longitudinal data from the Study of Women’s Health Across the Nation show that sleep disruption is not fully explained by vasomotor episodes. For many women, fragmented sleep is the first measurable indicator that the menopausal transition has begun.

Women aged 38 to 45 who develop new-onset insomnia often do not connect it to perimenopause. The association between menopause and hot flashes is so deeply embedded that sleep disruption without thermal episodes tends to get attributed to stress, aging, or anxiety. But the hormonal data tell a different story: progesterone drops before estrogen does, and progesterone is the hormone that maintains consolidated sleep.

This article covers why insomnia can precede every other perimenopause-related change, the hormonal timeline that makes this possible, and the wave pattern of sleep disruption that characterizes early perimenopause. For the broader overview of how hormonal changes affect sleep through multiple pathways, see Hormonal Women Sleep Disruption.

Hormonal changes are one of several causes of sleep disruption. The parent pillar covers the full picture — including cortisol, circadian, inflammatory, and metabolic contributors.


Does Progesterone Decline Before Estrogen in Early Perimenopause?

Yes. Data from the SWAN cohort and a review of 86 studies show that progesterone metabolites decline in early perimenopause while estrogen remains variable. Because progesterone metabolites — particularly allopregnanolone — maintain sleep through GABA-A receptor activation, their decline can disrupt sleep before estrogen-driven changes like hot flashes appear.

The timeline matters. In the Study of Women’s Health Across the Nation (SWAN), McConnell et al. (2021) analyzed daily urinary hormone levels in 763 women aged 43 to 53 in early perimenopause. Lowered pregnanediol glucuronide — the principal urinary metabolite of progesterone — combined with a variable luteinizing hormone pattern, reflecting anovulatory cycles, was associated with increased vasomotor episodes. Estradiol, at this stage, remained variable rather than uniformly low. The progesterone metabolite dropped first. The hot flashes came after.

This is not a single-study finding. Haufe, Baker, and Leeners (2022) published the largest review to date on ovarian hormones and perimenopausal sleep disruption, analyzing 86 studies across multiple designs. Their review indicated that: perimenopausal decline in estrogen and progesterone contributes to sleep disturbances, and that progesterone insufficiency may be an early driver of sleep disruption in the menopausal transition. Progesterone metabolites, particularly allopregnanolone, are positive allosteric modulators of GABA-A receptors. When these metabolites decline, the GABAergic tone that supports sleep maintenance weakens.

Line graph showing prevalence of three types of sleep difficulty across menopausal stages in 3,045 women
Prevalence of sleep difficulty across menopausal transition during longitudinal follow-up (average rates for each menopausal stage; N = 3,045). Kravitz, H. M., & Joffe, H. (2011). Sleep during the perimenopause: a SWAN story. Obstetrics and Gynecology Clinics of North America, 38(3), 567–586. https://pubmed.ncbi.nlm.nih.gov/21961720/

The SWAN longitudinal data (Kravitz & Joffe, 2011) tracked 3,045 women across menopausal stages and found that decrements in estradiol and increments in follicle-stimulating hormone (FSH) were associated with greater sleep disruption — even after controlling for age. Three types of sleep difficulty — trouble falling asleep, waking multiple times, and waking earlier than planned — all increased across the menopausal transition. The association persisted even in women without vasomotor episodes, though it was weaker — meaning the sleep disruption was not fully a downstream consequence of hot flashes. The hormones were affecting sleep through pathways that are not fully mediated by hot flashes.


Can You Have Perimenopause Insomnia Without Any Other Changes?

Yes. Polysomnography research demonstrates that the menopausal transition produces measurable beta-EEG hyperarousal — elevated brain alertness during sleep — that develops independently of hot flashes, night sweats, or any other vasomotor change. A proportion of women in the menopausal transition have a primary sleep disruption that is not secondary to thermal episodes.

Objective brain measurements — not self-report questionnaires — provide the strongest evidence for insomnia as an independent perimenopause feature.

Matthews et al. (2021) followed 159 women with in-home ambulatory polysomnography over approximately 3.5 years. At follow-up, women who had transitioned to postmenopause showed elevated beta-band EEG power during NREM sleep compared to women who remained premenopausal. Elevated beta power during sleep is an electrophysiological marker of cortical hyperarousal — the brain is more alert than it should be during rest. This elevation persisted after statistically controlling for self-reported hot flashes.

Line graph showing estimated NREM beta EEG power at two assessments across menopausal transition groups
Estimated means for NREM beta (log) at the first and second assessment by menopausal transition groups. Matthews, K. A., Lee, L., Kravitz, H. M., Joffe, H., Neal-Perry, G., Swanson, L. M., Evans, M. A., & Hall, M. H. (2021). Influence of the menopausal transition on polysomnographic sleep characteristics: a longitudinal analysis. Sleep, 44(11). https://pubmed.ncbi.nlm.nih.gov/34081126/

That dissociation is important. The menopausal transition itself — independent of whether a woman experiences hot flashes — drives measurable changes in sleep neurophysiology. Sleep duration and wakefulness after sleep onset did not differ between menopausal stage groups in this study, which suggests that the hyperarousal develops at the level of sleep architecture before it manifests as fragmented or shortened sleep. This may explain why some perimenopausal women report unrestorative sleep despite logging what appears to be adequate total sleep time.

Coborn et al. (2022) added further granularity. In an 8-week observational study of 45 perimenopausal women with weekly hormone measurements, estradiol levels in the postmenopausal range predicted increased nightly awakenings (beta = 0.14; P = 0.007), and higher FSH independently predicted more awakenings as well (beta = 0.12; P = 0.02). All of these hormonal associations were independent of vasomotor and depressive episodes. The hormones were associated with sleep disruption independently of hot flashes.

The experience women describe — “I wake up three times a night but I don’t have hot flashes, so my doctor says it can’t be hormonal” — has a measurable physiological basis.


Why Does Perimenopause Insomnia Come and Go in Waves?

In early perimenopause, progesterone and estrogen levels fluctuate erratically rather than following the predictable monthly cycle of reproductive years. Sleep quality tracks these fluctuations. A stretch of adequate progesterone produces normal sleep; a drop produces insomnia. The wave pattern is the hormonal fluctuation made visible in sleep.

A “good weeks and bad weeks” pattern is one of the least explained aspects of early perimenopause insomnia. Women describe stretches of normal sleep followed by ten days of waking at 2 or 3 AM, followed by another stretch of consolidated sleep. The inconsistency makes it difficult to identify a cause — and easy to attribute the bad stretches to stress or diet changes rather than hormonal fluctuation.

While McConnell et al. (2021) studied vasomotor episodes rather than sleep directly, their SWAN daily-hormone data help explain the hormonal pattern behind this. In the 763 women studied, progesterone metabolite excretion was variable and unpredictable in early perimenopause. Cycles alternated between ovulatory (with adequate luteal progesterone) and anovulatory (with insufficient progesterone). The anovulatory cycles produced the progesterone drops associated with reduced progesterone. Because the alternation between ovulatory and anovulatory cycles is itself unpredictable in early perimenopause, the resulting insomnia appears in irregular waves rather than a steady decline.

Kravitz and Joffe (2011) documented this variability in the SWAN cohort of 3,045 women: sleep disruption intensity varied with hormonal status across the transition, with the greatest sleep variability corresponding to the greatest hormonal fluctuations. Late perimenopause, when hormone levels are more consistently low, tends to produce more consistent (though still disrupted) sleep patterns. Early perimenopause — when hormone levels are swinging between adequate and insufficient — generates the chaotic, wave-like insomnia.

The Haufe, Baker, and Leeners (2022) 86-study review supports this: the irregular nature of hormonal decline in perimenopause, as opposed to the more gradual and consistent decline of postmenopause, may produce the intermittent insomnia pattern. Postmenopausal women report more stable sleep patterns — disrupted, but predictably so. Perimenopausal women report the opposite: unpredictable stretches of normal sleep punctuated by unexplained bouts of insomnia.

This wave pattern is itself a distinguishing feature. Insomnia driven by chronic stress or anxiety tends to be more constant. Insomnia that comes in waves — good stretches followed by bad stretches, with no obvious external trigger — is consistent with the erratic hormonal fluctuations of early perimenopause.


Many people have more than one cause contributing to their sleep disruption. Hormonal changes that produce intermittent insomnia may compound with autonomic, metabolic, inflammatory, or circadian factors — and those additional causes do not fluctuate in waves. Identifying which causes might be involved is a useful next step.

Find out which causes might be driving your 3am wakeups →


Frequently Asked Questions

Is Insomnia the First Sign of Perimenopause?

It can be. Research shows that progesterone-driven sleep disruption can precede estrogen-driven changes like hot flashes. In the SWAN cohort, sleep disruption was independently associated with hormonal markers of the menopausal transition — supporting insomnia as a standalone early indicator rather than a downstream effect of other changes.

The SWAN data (Kravitz & Joffe, 2011) provide direct evidence for this timeline. Decrements in estradiol and increments in FSH — both markers of the menopausal transition — were associated with sleep disruption, controlling for age and vasomotor status. This means the hormonal markers were associated with sleep disruption even in women who had no hot flashes.

This does not mean that insomnia is always hormonal. Other causes of new-onset insomnia in the late 30s and 40s include autonomic dysregulation, inflammatory load, and circadian changes. But when insomnia appears without an identifiable external cause in a woman in this age range, the hormonal pathway is one to investigate.

Can Perimenopause Start in Your Late 30s?

Yes. Perimenopause typically begins 4 to 8 years before the final menstrual period, with the average age of menopause at 51. That puts the onset in the early-to-mid 40s for many women, though it can begin in the late 30s. Early onset — defined as beginning before age 40 — affects approximately 1% of women, while onset between 40 and 45 affects roughly 5%.

The variability in timing matters. Some women begin experiencing anovulatory cycles and progesterone decline in their late 30s. Because early perimenopause can be subtle — the menstrual cycle may still appear regular even when luteal progesterone is already declining — the hormonal transition can begin before any external marker would suggest it (Haufe, Baker, & Leeners, 2022).

Haufe, Baker, and Leeners (2022) show that the perimenopause-to-menopause transition spans a wide age range across populations, and that the earliest hormonal changes — including progesterone metabolite decline — can precede menstrual irregularity.

Why Didn’t Your Doctor Connect Your Insomnia to Perimenopause?

Physician training on menopause focuses on vasomotor changes — hot flashes and night sweats — as the primary indicators. Insomnia without vasomotor changes does not match the pattern that physicians are trained to recognize. A 2025 meta-analysis of perimenopausal sleep disorders identified hot flashes and depression as prominent risk factors — reflecting the research emphasis on vasomotor and mood-related pathways.

Zeng et al. (2025) analyzed 12 studies involving 11,928 perimenopausal women and found that hot flashes (OR = 2.70) and depression (OR = 2.73) were among the strongest risk factors for sleep disorders in this population. The research itself has been organized around these associations — which means the pathway where insomnia develops independently of both hot flashes and mood changes has received less attention. When a woman presents with insomnia but no hot flashes and no depression, the presentation does not fit the studied profile, and the hormonal connection is less likely to be identified.

For a deeper examination of why standard blood work often does not capture early perimenopause, see Your Blood Tests Are Normal But You Can’t Sleep.

Does Perimenopause Insomnia Without Hot Flashes Respond to the Same Approaches?

Partially. Progesterone supplementation directly addresses the GABA deficit driving sleep disruption and has shown benefit in menopausal insomnia. Estrogen-based hormone replacement targets vasomotor changes primarily. CBT-I (cognitive behavioral therapy for insomnia) addresses the cognitive and behavioral patterns that develop around any insomnia. The approach that matches the mechanism depends on which hormonal pathway is driving the disruption.

The Haufe, Baker, and Leeners (2022) review found that both estrogen and progesterone replacement improved sleep quality across multiple study types. Progesterone acts through neurosteroid metabolites that modulate GABA-A receptors — directly enhancing the sleep-maintenance mechanism that early perimenopause weakens. Estrogen acts primarily through thermoregulatory stabilization, which addresses hot flash-mediated awakenings.

For women whose insomnia is not accompanied by hot flashes, the progesterone pathway may be more relevant than the estrogen pathway. For detailed evidence on each: Does HRT Help with Sleep in Menopause? and Does Progesterone Help You Sleep?.

How Do You Know If Your Insomnia Is Hormonal or Something Else?

Hormonal insomnia in early perimenopause has characteristics that distinguish it from other causes: it tends to come in waves (good stretches followed by bad stretches), primarily affects sleep maintenance rather than sleep onset, and does not respond fully to standard sleep hygiene improvements. If insomnia appeared in your late 30s or 40s without an identifiable external stressor, follows a wave pattern, and centers on waking during sleep rather than difficulty falling asleep, the hormonal pathway is one to investigate.

The Matthews et al. (2021) polysomnography data provide a useful framework. The cortical hyperarousal they measured — elevated beta-EEG power during NREM sleep — was specific to the menopausal transition. It developed independently of vasomotor episodes, mood disturbance, and age. The physiological signature was distinct from the hyperarousal patterns associated with generalized anxiety or chronic stress.

Pattern recognition can help narrow the possibilities. Hormonal perimenopause insomnia tends to center on sleep maintenance (waking at 2 AM, 3 AM, 4 AM) rather than sleep onset difficulty. It fluctuates in waves that do not correspond to identifiable stressors. And it is often accompanied by a sense that sleep is unrestorative even when total sleep time appears adequate — consistent with the subclinical hyperarousal that Matthews et al. documented at the EEG level.

This is not a self-assessment tool. Multiple causes of sleep disruption can produce overlapping patterns. But the wave pattern, the maintenance-focused disruption, and the absence of an external trigger form a recognizable cluster that points toward the hormonal pathway. For the full picture of why standard testing often misses this connection, see Your Blood Tests Are Normal But You Can’t Sleep.


Related Reading


References

1. Kravitz, H. M., & Joffe, H. (2011). Sleep during the perimenopause: a SWAN story. Obstetrics and Gynecology Clinics of North America, 38(3), 567–586. https://pubmed.ncbi.nlm.nih.gov/21961720/

2. Haufe, A., Baker, F. C., & Leeners, B. (2022). The role of ovarian hormones in the pathophysiology of perimenopausal sleep disturbances: A systematic review. Sleep Medicine Reviews, 66, 101710. https://pubmed.ncbi.nlm.nih.gov/36356400/

3. McConnell, D. S., Crawford, S. L., Gee, N. A., Bromberger, J. T., Kazlauskaite, R., Avis, N. E., Crandall, C. J., Joffe, H., Kravitz, H. M., Derby, C. A., Gold, E. B., El Khoudary, S. R., Harlow, S., Greendale, G. A., & Lasley, B. L. (2021). Lowered progesterone metabolite excretion and a variable LH excretion pattern are associated with vasomotor episodes but not negative mood in the early perimenopausal transition: Study of Women’s Health Across the Nation. Maturitas, 147, 26–33. https://pubmed.ncbi.nlm.nih.gov/33832644/

4. Matthews, K. A., Lee, L., Kravitz, H. M., Joffe, H., Neal-Perry, G., Swanson, L. M., Evans, M. A., & Hall, M. H. (2021). Influence of the menopausal transition on polysomnographic sleep characteristics: a longitudinal analysis. Sleep, 44(11). https://pubmed.ncbi.nlm.nih.gov/34081126/

5. Coborn, J., de Wit, A., Crawford, S., Nathan, M., Rahman, S., Finkelstein, L., Wiley, A., & Joffe, H. (2022). Disruption of Sleep Continuity During the Perimenopause: Associations with Female Reproductive Hormone Profiles. The Journal of Clinical Endocrinology and Metabolism, 107(10), e4144–e4153. https://pubmed.ncbi.nlm.nih.gov/35878624/

6. Zeng, W., Xu, J., Yang, Y., Lv, M., & Chu, X. (2025). Factors influencing sleep disorders in perimenopausal women: a systematic review and meta-analysis. Frontiers in Neurology, 16, 1460613. https://pubmed.ncbi.nlm.nih.gov/39990264/


Written by Kat Fu, M.S., M.S. · Last reviewed: May 2026 · 6 references cited

Scroll to Top